Click to add date | Click to add location
Bree Collaborative Implementation Survey Results for Medical Groups - - PowerPoint PPT Presentation
Bree Collaborative Implementation Survey Results for Medical Groups - - PowerPoint PPT Presentation
Bree Collaborative Implementation Survey Results for Medical Groups & Hospitals Paul Gruen, Implementation Consultant Click to add date | Click to add location 13 Bree Collaborative Topics, 1 to 115 recommendations per topic Obstetrics
13 Bree Collaborative Topics, 1 to 115 recommendations per topic
Obstetrics Care Cardiology: Appropriate PCI CABG Surgical Bundle Spine/Low Back Pain Spine SCOAP Lumbar Fusion Surgical Bundle Knee/Hip Replacement Prostate Cancer Screening Oncology Care Addiction & Dependence Treatment Opioid Prescriptions End Of Life Care Planning Avoidable Hospital Readmissions
Slide 2
Implementation Survey
Separate hospital and medical group surveys Surveys are voluntary, self-reported (inter-rater reliability) Bias towards larger urban & suburban systems Implementation possibly independent of Bree Recommendation Low implementation could mean “unknown” Extensive length of survey reduced response rate
Slide 3
Participating Hospitals &Medical Groups
CHI Franciscan Health
5 hospitals
Confluence Health
Hospital & medical group
The Everett Clinic Evergreen Health Partners Group Health Northwest Physicians Network Polyclinic Swedish/Providence
5 hospitals, 3 medical groups
UW
4 hospitals
Vancouver Clinic Virginia Mason
Hospital & medical group
Slide 4
Implementation Scoring Scale
0 -No action taken 1 -Actively considering adoption 2 -Some/similar adoption 3 -Full adoption
Slide 5
MG #1: Addiction & Dependence Treatment (Average Score: 1.46)
Slide 6
20 40 60 80 100 1 2 3 Count Assessment Score (28 recommendations x 10 medical groups)
MG #1: Addiction & Dependence Treatment (lowest scoring recommendations)
Verbal communication takes place with the chemical dependency treatment facility to follow-up on any referrals and assess whether treatment was initiated and/or completed (0.75) The patient’s perspective is included as work is done to increase the capability of the chemical dependency system (0.75) Patients are contacted after they have been referred to chemical dependency treatment to address any barriers to accessing treatment (0.88) Patient results from alcohol and other drug misuse screens are tracked
- ver time (1.00)
Slide 7
MG #8: Obstetrics (Average Score: 2.74)
Slide 8
5 10 15 20 25 30 1 2 3 Count Assessment Score (5 recommendations x 7 medical groups)
Knee and Hip Replacement Surgical Bundle
11 hospitals 87 recommendations 2.32 Average Score
Slide 9
10 20 30 40 50 1 2 3
Count Assessment Score
Cycle 1: Disability Despite Conservative Therapy
(9 recommendations)
50 100 150 200 1 2 3
Count Assessment Score
Cycle 2: Fitness for Surgery
(31 recommendations)
20 40 60 80 100 120 140 1 2 3
Count Assessment Score
Cycle 3: Repair of Joint
(18 recommendations)
20 40 60 80 100 120 1 2 3
Count Assessment Score
Cycle 4: Return to Function
(19 recommendations)
Knee and Hip Replacement Surgical Bundle (5 lowest scoring recommendations)
Cycle 2: General health questionnaire completed: Patient Reported Outcomes Measurement Information System-10/PROMIS-10 (1.09) Cycle 2: Patient participates in Shared Decision-making with WA State- approved Decision Aid (1.36) Cycle 2: HOOS/KOOS survey completed (1.60) Cycle 4: Patient-reported functional outcomes are measured with KOOS/HOOS instrument (1.55) Cycle 4: If opioid use exceeds six weeks, a formal plan is developed for
- pioid management (1.55)
Slide 10
Hospitals: Appropriate PCI / COAP (Average Score: 3.00)
Slide 11
5 10 15 20 25 1 2 3 Count Assessment Score (3 recommendations x 7 hospitals)
Top BARRIERS to Adoption
Slide 12
Lack of availability & credibility of data, and burden to collect it Business case- no economic reward, and lack of contract partners interested in value-based purchasing Lack of consensus on what constitutes quality of care
Top ENABLERS to Adoption
Existing organizational improvement program for minimizing errors & waste Business case- evidence of economic reward Consensus on what constitutes quality of care Individual provider-level performance feedback
Slide 13
Implementation- Key Lessons: 1 - 4
- 1. Systematic collection of patient self-reported goals, function &
- utcomes tracking are a challenge (STarT Back tool, Functional
Recovery Questionnaire, Oswestry, PROMIS-10, KOOS/HOOS, Opioid pain assessment, Cancer Care treatment goals)
- 2. Patient Decision Aids not yet available and shared decision making
not systematic (Prostate/PSA testing, knee/hip replacement)
- 3. Some recommendations may not be adopted as broadly as Bree
specifies (advance care plans >18 y.o., drug & alcohol screening in ED >13 y.o.)
- 4. Communication between entities not systematic (advanced
directives/POLST, PMP for Opioids)
Slide 14
Key Lessons: 5-10
- 5. Long-term opioid use planning a challenge, also Prescription Monitoring
Program (PMP)
- 6. Addiction/dependency referrals, follow-up and tracking not systematic
- 7. Alignment with “Choosing Wisely” an opportunity (Oncology care,
Prostate/PSA screening)
- 8. Decisions by “Collaborative Team” not yet systematic (Lumbar Fusion)
- 9. Data issues, business case for implementation significant barriers
- 10. Organization improvement program, business case, provider level
performance feedback significant enablers
Slide 15
Next Steps (work in process)
Closer examination of providers successful in implementation Work with health plans, particularly on business case
WA state “Business Group on Health”?
Healthier Washington/Hub, also Patient Decision Aids Choosing Wisely Bundled Payment specifications- revise/update
Slide 16